How New Training Partnership is Advancing Medical Device Knowledge & Professional Development

Global Medical Device Podcast · 16 Jun 2021 · 15m · Episode 214

What this episode covers

Peter Sebelius, founder and CEO of Medical Device HQ, joins Greenlight Guru host Jon Speer to discuss a new strategic partnership that integrates Medical Device HQ’s training courses into the Greenlight Guru Academy. Sebelius explains the pedagogical value of his blended learning approach, which combines self-paced online modules with formative assessments and live virtual sessions, arguing that understanding the 'why' behind FDA regulations is crucial for effective quality management. The conversation highlights how this model addresses the inefficiencies of traditional in-person training by offering global accessibility, cost-effectiveness, and environmental benefits, particularly accelerated by the pandemic.

Other shows on the same ground, closest first.

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

  • Being an Engineer · 51m

    S5E29 Steve Gompertz | Medical Device Quality Control & Regulatory Requirements

    Steve Gompertz, a partner at QRx Partners with prior leadership roles at Medtronic, Boston Scientific, St. Jude Medical, and Pelican Biothermal, explains how to build scalable quality management systems for medical device companies. He details the evolution of regulatory frameworks, noting the shift toward stricter EU standards and the integration of AI and cybersecurity into device compliance. Gompertz emphasizes tailoring quality systems to company size, using a case study of a client who reduced FDA findings from dozens to zero by implementing a holistic, process-connected system rather than a checklist approach. He also advocates for concurrent engineering and cross-functional teams to accelerate development while maintaining rigorous safety standards.

  • Let's Combinate · 32m

    107 - Distilling Decades of MedTech Data, Generative AI, and Doing Without Tribal Knowledge with Michelle Wu

    Michelle Wu, CEO and Founder of NyquistData, explains how her company uses generative AI to distill decades of MedTech data, removing the 'tribal knowledge' barrier for quality and regulatory professionals. She details the distinction between pre-trained models and fine-tuned algorithms, emphasizing that Nyquist’s data is validated and specific to FDA and global medical device regulations, unlike generic models like OpenAI. Wu discusses the challenge of changing organizational culture and overcoming skepticism in life sciences, highlighting features like the 'Device Explorer' and 'Data Writer' that democratize access to complex regulatory insights.

  • Let's Combinate · 41m

    135 - Combination Products Mindset, MDUFA and Combination Products, FDA Hierarchy, Supplier Management, Surprises in Industry, and Culture with Tony Watson

    Tony Watson, Vice President of Regulatory and Quality at Windgap Medical, discusses the evolution of combination product regulation, tracing the creation of the Office of Combination Products (OCP) and the impact of MDUFA on FDA structure and resources. He details his transition from FDA reviewer to industry roles at Biogen and Sanofi, highlighting the challenges of establishing device competency within large pharmaceutical organizations and the unique supply chain dynamics of startups like Windgap. Watson emphasizes the critical importance of a 'combination product mindset' that balances drug and device perspectives, fostering a culture where dissenting opinions are heard to ensure quality and safety.

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.